What Are Treatments For Mucosa-Associated Lymphoid Tissue Lymphoma?

What are treatments for Mucosa-Associated Lymphoid Tissue Lymphoma?

The treatment for Mucosa-Associated Lymphoid Tissue (MALT) lymphoma depends on various factors, including the location and stage of the lymphoma, the patient's overall health, and individual preferences. MALT lymphoma is often considered a slow-growing and indolent (low-grade) type of non-Hodgkin lymphoma, and treatment approaches aim to achieve remission while minimizing side effects. Here are some common treatment options for MALT lymphoma:

1. Watchful Waiting (Active Surveillance):

In some cases, especially when MALT lymphoma is in an early stage and not causing significant symptoms, a healthcare provider may recommend a "watch-and-wait" approach. This means closely monitoring the lymphoma without immediate treatment. Treatment is initiated only if the lymphoma progresses or causes symptoms.

2. Localized Radiation Therapy:

Radiation therapy is a common treatment for MALT lymphoma, especially when the lymphoma is localized to a specific site, such as the stomach, lung, or salivary glands. Radiation therapy focuses high-energy beams precisely on the affected area to destroy cancer cells.

3. Chemotherapy:

Chemotherapy may be considered for advanced-stage or more aggressive cases of MALT lymphoma, or when the lymphoma has spread to multiple sites. Chemotherapy involves the use of drugs to kill or slow the growth of cancer cells throughout the body:

• CHOP Regimen: The CHOP regimen is a commonly used chemotherapy protocol for various types of non-Hodgkin lymphoma, including some cases of MALT lymphoma. It consists of the following drugs:

  Rituximab, a monoclonal antibody that targets B cells, is often added to the CHOP regimen in cases of MALT lymphoma, creating the R-CHOP regimen. This combination has been shown to be effective in some cases.

  • Cyclophosphamide
  • Doxorubicin (Adriamycin)
  • Vincristine (Oncovin)
  • Prednisone (a corticosteroid)

• CVP Regimen: The CVP regimen is another chemotherapy option for MALT lymphoma and consists of the following drugs:

  Similar to the CHOP regimen, rituximab can be added to create the R-CVP regimen, which may be used in some cases.

  • Cyclophosphamide
  • Vincristine
  • Prednisone

• Bendamustine: Bendamustine is a chemotherapy drug that has been used as a single agent or in combination with rituximab in the treatment of MALT lymphoma. It has shown efficacy with a relatively favorable side effect profile.

• Fludarabine-based Regimens: In some cases, fludarabine-based chemotherapy regimens may be considered for MALT lymphoma. These regimens may be used in relapsed or refractory cases or for more aggressive subtypes of MALT lymphoma.

• Other Chemotherapy Combinations: Depending on the specific characteristics of the MALT lymphoma, other chemotherapy combinations may be considered. Treatment decisions should be made in consultation with a hematologist or oncologist experienced in the management of lymphomas.

4. Targeted Therapies:

Some MALT lymphomas may be driven by specific genetic or molecular abnormalities. Targeted therapies designed to interfere with these specific mechanisms may be used in some cases.

5. Surgery:

Surgical removal of the affected tissue may be considered in specific cases, such as when the lymphoma is confined to a single site and surgery can be curative.

6. Antibiotics:

In cases where MALT lymphoma is associated with chronic infections, such as Helicobacter pylori (H. pylori) in the stomach or Chlamydia psittaci in the ocular adnexa, antibiotic therapy to eradicate the infection may lead to remission of the lymphoma.

7. Clinical Trials:

Participation in clinical trials may be an option for some patients, especially those with refractory (does not respond to treatment) or relapsed (returns after treatment) MALT lymphoma. Clinical trials can offer access to innovative treatments and therapies under investigation.

To learn more about your MALT clinical trial options, visit HealthTree's MALT Clinical Trial Finder. Utilize the advanced filter option to locate trials that you are eligible to participate in. You can create a HealthTree account to favorite your top trial options so you can discuss them with your ALL specialist.

The choice of treatment depends on a careful assessment of the individual patient's condition, including the stage and location of the lymphoma, the extent of symptoms, and the patient's overall health. Treatment decisions should be made in consultation with a hematologist, oncologist, or a medical team experienced in treating lymphomas.

It's important to note that many individuals with MALT lymphoma respond well to treatment and may achieve long-term remission or even be cured. The specific treatment plan and prognosis can vary widely among patients, so it's crucial to have open and informed discussions with healthcare providers to determine the most appropriate approach to managing MALT lymphoma.

Want to learn more about Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma? 

Keep reading Healthtree’s MALT Lymphoma 101 pages!

What are the signs and symptoms of mucosa-associated lymphoid tissue lymphoma?

How long will I live with mucosa-associated lymphoid tissue lymphoma?

How is mucosa-associated lymphoid tissue lymphoma staged and classified??

How is mucosa-associated lymphoid tissue lymphoma diagnosed??

What is mucosa-associated lymphoid tissue (MALT) lymphoma??